Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 4:43 pm Sale | 13G | MATINAS BIOPHARMA HLDGS INC CO MTNB | Boxer Capital LLC | 0 0% | -11,478,634 (Position Closed) | View |
| 2022-02-14 4:40 pm Sale | 13G | SOLID BIOSCIENCES INC SLDB | Boxer Capital LLC | 5,336,031 4.7% | -864,230 (-13.94%) | View |
| 2022-02-14 4:40 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 4,082,576 3.6% | -6,226,674 (-60.40%) | View |
| 2022-02-14 4:40 pm Sale | 13G | CABALETTA BIO INC CABA | Boxer Capital LLC | 540,000 1.9% | -1,063,361 (-66.32%) | View |
| 2022-02-14 4:36 pm Sale | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Boxer Capital LLC | 1,067,299 1.9% | -2,700,000 (-71.67%) | View |
| 2022-02-14 4:33 pm Sale | 13G | ARS PHARMACEUTICALS, INC SPRY | Boxer Capital LLC | 0 0% | -1,675,377 (Position Closed) | View |
| 2022-02-14 4:28 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Boxer Capital LLC | 0 0% | -4,800,000 (Position Closed) | View |
| 2022-02-14 4:22 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | Boxer Capital LLC | 0 0% | -4,000,000 (Position Closed) | View |
| 2022-02-14 4:21 pm Sale | 13G | ELEVATION ONCOLOGY INC ELEV | Boxer Capital LLC | 872,780 3.8% | -468,750 (-34.94%) | View |
| 2022-02-14 4:19 pm Sale | 13G | F-STAR THERAPEUTICS INC FSTX | Boxer Capital LLC | 0 0% | -1,501,428 (Position Closed) | View |
| 2022-02-14 4:17 pm Purchase | 13G | THERAPEUTICS ACQUISITION CORP RACA | Boxer Capital LLC | 2,500,000 2.8% | 1,000,000 (+66.67%) | View |
| 2022-02-14 4:16 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Boxer Capital LLC | 2,838,236 6.3% | 570,000 (+25.13%) | View |
| 2022-02-14 4:14 pm Sale | 13G | TALIS BIOMEDICAL CORP COM TLIS | Boxer Capital LLC | 0 0% | -1,550,998 (Position Closed) | View |
| 2022-02-14 4:10 pm Sale | 13G | BIOMEA FUSION INC BMEA | Boxer Capital LLC | 1,188,405 4.1% | -900,000 (-43.10%) | View |
| 2022-02-14 4:10 pm Purchase | 13G | MERUS N V COM MRUS | Boxer Capital LLC | 1,900,000 4.4% | 300,000 (+18.75%) | View |
| 2022-01-05 9:26 pm Sale | 13D | ITEOS THERAPEUTICS INC. ITOS | Boxer Capital LLC | 3,717,259 10.54% | -627,757 (-14.45%) | View |
| 2021-11-26 5:01 pm Sale | 13D | ODONATE THERAPEUTICS INC ODT | Boxer Capital LLC | 4,207,086 10.9% | -400,000 (-8.68%) | View |
| 2021-11-22 11:08 am Sale | 13D | ODONATE THERAPEUTICS INC ODT | Boxer Capital LLC | 4,607,086 12% | -159,800 (-3.35%) | View |
| 2021-09-24 4:30 pm Purchase | 13D | TYRA BIOSCIENCES INC TYRA | Boxer Capital LLC | 6,323,359 14.9% | 6,323,359 (New Position) | View |
| 2021-07-09 4:31 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | Boxer Capital LLC | 1,341,530 5.9% | 1,341,530 (New Position) | View |